This award, generously supported by AstraZeneca, is made every 3 years in recognition of outstanding work which, through biomedical advances, leads to development of a new reagent or method. The research should have been carried out in a UK or Republic of Ireland laboratory.
The winner is given:
- £2000 prize money
- The opportunity to present a lecture at Biochemical Society event.
- Invited to submit an article to a Society-owned publication.
The 2019 winner Ervin Fodor presented his award lecture at the Biochemical Society conference ‘Transcriptions in Health and Disease’ on 20-22 November 2019 in London, UK.